Hybrid endoscopy system could detect early ovarian cancer

Share this content:

The combining of three imaging tools into one device may provide a new, minimally invasive approach to diagnosing early-stage ovarian cancer in high-risk women. According to the researchers, the new technique may be better than the current standard procedure of preemptively removing a woman's ovaries.

Yi Yang, of the electrical and computer engineering department at the University of Connecticut in Storrs, and colleagues integrated optical coherence tomography (OCT), ultrasound (US), and photoacoustic imaging (PAI) to create a prototype endoscopy system for ovarian tissue characterization. As the researchers noted in Biomedical Optics Express (2011;2[9]:2551-2561; www.opticsinfobase.org/abstract.cfm?URI=boe-2-9-2551), ovarian cancer has the lowest survival rate of the gynecologic cancers because it is predominantly diagnosed in Stages III or IV due to the lack of reliable symptoms as well as the lack of effective screening techniques.

With OCT providing high-resolution subsurface imaging, pulse-echo US providing deeper tissue structure imaging, and PAI providing optical absorption contrast, the device correctly identified malignant tumors in both pig and human ovarian tissues. Yang's group reported that the hybrid device was performed better than each modality alone in ovarian tissue characterization.

Although the tissues used in these experiments had been surgically removed, the small (5 mm) diameter of the new imaging device makes possible the concept of inserting it into a small incision so that imaging could be performed in live patients.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs